Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E27.96 EPS (ttm)1.25 Insider Own0.20% Shs Outstand2.45B Perf Week-0.68%
Market Cap85.72B Forward P/E12.46 EPS next Y2.81 Insider Trans0.00% Shs Float2.44B Perf Month-14.70%
Income3.08B PEG3.11 EPS next Q0.68 Inst Own10.30% Short Float0.59% Perf Quarter-9.36%
Sales39.75B P/S2.16 EPS this Y-89.20% Inst Trans5.87% Short Ratio3.24 Perf Half Y-19.03%
Book/sh0.70 P/B50.09 EPS next Y-3.30% ROA4.00% Target Price43.67 Perf Year-8.82%
Cash/sh2.60 P/C13.47 EPS next 5Y9.00% ROE189.00% 52W Range34.72 - 44.53 Perf YTD-8.96%
Dividend2.01 P/FCF26.37 EPS past 5Y-28.90% ROI8.60% 52W High-21.13% Beta0.98
Dividend %5.73% Quick Ratio0.40 Sales past 5Y0.40% Gross Margin69.30% 52W Low1.17% ATR0.52
Employees99827 Current Ratio0.60 Sales Q/Q4.00% Oper. Margin13.90% RSI (14)27.20 Volatility0.92% 1.25%
OptionableYes Debt/Eq14.71 EPS Q/Q48.80% Profit Margin7.70% Rel Volume0.93 Prev Close35.06
ShortableYes LT Debt/Eq11.05 EarningsOct 25 Payout167.30% Avg Volume4.43M Price35.13
Recom2.50 SMA20-3.54% SMA50-9.75% SMA200-14.35% Volume3,886,648 Change0.19%
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-20-17 07:53AM  Is GlaxoSmithKline plc (LSE:GSK) Undervalued? Simply Wall St.
07:50AM  Corporate News Blog - GlaxoSmithKline and Innovivas Trelegy Ellipta Gets Marketing Authorization for the Treatment of COPD in Europe ACCESSWIRE
Nov-17-17 04:41PM  Theravance Shares Rise on Approval of Glaxo's COPD Therapy Zacks
03:16PM  Glaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU Zacks
Nov-16-17 11:26AM  AstraZenecas Valuation after 3Q17 Earnings Market Realist
03:08AM  Europe approves GlaxoSmithKline's new triple lung drug Reuters
02:00AM  Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation in Europe for the Treatment of COPD Business Wire
12:37AM  [$$] Gates Foundation, Abu Dhabi Pair to Fight Forgotten Diseases The Wall Street Journal
Nov-15-17 03:01PM  [$$] Gates Foundation, Abu Dhabi Pair to Fight Forgotten Diseases The Wall Street Journal
01:04PM  VBI Vaccines Could Nearly Triple In Value On New Drug Launches, According To BMO Benzinga
09:47AM  AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA Zacks
09:01AM  Behind Novartiss Respiratory Drug Performance in 3Q17 Market Realist
Nov-14-17 03:14PM  9 More Companies Whose Dividend Is in Danger InvestorPlace
09:48AM  Glaxo's Subcutaneous Formulation of Benlysta Approved in EU Zacks
03:02AM  Top LSE Dividend Picks For The Day Simply Wall St.
Nov-13-17 01:00PM  VBI: Multiple Platforms Yield a Portfolio of Vaccines Zacks Small Cap Research
12:26PM  ETFs with exposure to GlaxoSmithKline Plc : November 13, 2017 Capital Cube
05:27AM  Bill Gates Is Now Tackling Alzheimers With a Huge Investment in Dementia Research Fortune
Nov-11-17 07:23AM  It's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine Approval Motley Fool
Nov-10-17 10:37AM  GlaxoSmithKline Plc : GSK-US: Dividend Analysis : November 10th, 2017 (record date) : By the numbers : November 10, 2017 Capital Cube
09:03AM  Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod Zacks
08:58AM  Adaptimmune Presents Study Designs for Ongoing MAGE-A4 and NY-ESO SPEAR T-cell Clinical Trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire
Nov-09-17 02:00PM  AstraZeneca's Dividend Commitment Comes at a Cost Bloomberg
08:00AM  NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmunes SPEAR T-Cell Therapy GlobeNewswire
07:47AM  AstraZeneca rides China wave as rival GlaxoSmithKline struggles Reuters
02:53AM  Hikma, Vectura in dispute with FDA over generic Advair Reuters
Nov-08-17 03:04PM  Dynavax Awaits FDA Verdict On Hepatitis B Vaccine Benzinga
03:00PM  Largest Shareholders of GlaxcoSmithKline Investopedia
02:30PM  GlaxoSmithKline R&D leader departing for UK government job American City Business Journals
01:37PM  [$$] Glaxo Names Roche Veteran as R&D Head The Wall Street Journal
12:52PM  [$$] GlaxoSmithKline appoints Hal Barron as R&D chief Financial Times
12:00PM  GSK grabs Roche veteran and Calico scientist Barron as new R&D head Reuters
10:39AM  Here's What Cost GlaxoSmithKline PLC Nearly $10 Billion in Market Cap in October Motley Fool
09:12AM  GSK nabs Calico scientist Barron as new R&D head, Vallance quits Reuters
Nov-07-17 07:33AM  3 International Stocks for Retirees Motley Fool
Nov-06-17 12:43PM  Glaxo vs Gilead: Put 'Em Up?
08:09AM  Adaptimmune marks Official Opening of U.K. Headquarters GlobeNewswire
Nov-03-17 02:22PM  Adaptimmune to Present Two Trials in Progress Posters at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire
02:17PM  Adaptimmune Data to be Presented in an Oral Presentation and a Trial in Progress Poster at the Connective Tissue Oncology Society (CTOS) Annual Meeting GlobeNewswire
03:45AM  GSK's R&D head to leave for top UK government job - source Reuters
Nov-02-17 10:38AM  GSK and Gilead go head to head as HIV drugs enter new phase Reuters
08:18AM  GlaxoSmithKline Wins FDA Approval to Develop 'Breakthrough' Blood Cancer Drug
04:28AM  GSK gets boost for early cancer hopes with breakthrough status Reuters
Nov-01-17 12:12PM  ETFs with exposure to GlaxoSmithKline Plc : November 1, 2017 Capital Cube
10:18AM  Pfizer Inc. Stock Earnings Were a Snooze But Thats Good InvestorPlace
07:00AM  GSK Study Demonstrates Superiority of Anoro Ellipta to Stiolto Respimat in Improving Lung Function in Chronic Obstructive Pulmonary Disease Business Wire
Oct-31-17 04:51PM  Novartis Buys French Radiopharmaceutical Company Zacks
Oct-30-17 10:27AM  2 Top Pharma Stocks on Sale This Week Motley Fool
10:14AM  GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017 Capital Cube
10:01AM  Foreign Stock Roundup: Novartis, Bayer, Glaxo, Total Beat on Earnings Zacks
06:00AM  10 Cheap Foreign Stocks With Moats Morningstar
Oct-27-17 08:50AM  Pharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers Zacks
Oct-26-17 12:31PM  Glaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down Zacks
08:44AM  GlaxoSmithKline's new boss struggles to sell cure for drugmaker Reuters
06:00AM  Exclusive: Pfizer to launch consumer health sale in November - sources Reuters
01:34AM  Exclusive: Pfizer to launch consumer health sale in November -sources Reuters
Oct-25-17 08:14PM  PRESS DIGEST- British Business - Oct 26 Reuters -5.66%
07:36PM  Warren Prods AIG Non-SIFI Label, GSK Joins List of Pfizer Consumer Beaus--ICYMI
05:16PM  Panel recommends new, better shingles shot over old version Associated Press
04:20PM  Could GlaxoSmithKline Scoop Up Pfizer's Over-The-Counter Unit? Investor's Business Daily
03:59PM  Panel recommends new, better shingles shot over old version Associated Press
03:50PM  Exclusive: Pfizer to launch consumer health sale in November: sources Reuters
03:30PM  Pfizer to Sell Consumer Healthcare Business Next Month
02:39PM  Exclusive: Pfizer to launch consumer health sale in November - sources Reuters
01:52PM  CDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up PR Newswire
01:45PM  GlaxoSmithKline Can't Have it All Bloomberg
01:28PM  U.S. committee recommends GSK shingles vaccine over Merck rival Reuters
12:54PM  GlaxoSmithKline stock plummets 6% after concerns about dividend risk MarketWatch
11:41AM  Correction: FDA-Shingles Vaccine story Associated Press
11:34AM  Glaxo's CEO Sees Real Costs From Brexit, Pushes for Clarity Bloomberg
11:30AM  GSK ready to build drug testing in EU as Brexit looms Reuters
11:30AM  GSK may bid for Pfizer consumer unit, stoking dividend fears Reuters
11:00AM  [$$] Glaxo Will Consider Bid for Pfizer's Consumer-Health Unit The Wall Street Journal
10:44AM  [$$] GSK draws up shopping list for Pfizer and Merck consumer units Financial Times
09:36AM  GSK to study consumer health buys but pharma top priority Reuters
09:21AM  GSK to study consumer health buys but pharma top priority Reuters
08:03AM  Glaxo beats Street 3Q forecasts Associated Press
07:53AM  Glaxo (GSK) Q3 Earnings Surpass Estimates, Revenues In Line Zacks
07:44AM  Drugmaker GSK sees sales rise thanks to new products Associated Press
07:08AM  HIV pills and new lung drugs keep GSK on track in Q3 Reuters
06:01AM  Futures point to a mixed open as earnings deluge continues CNBC
Oct-24-17 09:12AM  Drug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX Zacks
08:52AM  Should You Buy GlaxoSmithKline (GSK) Ahead of Earnings? Zacks
07:50AM  Corporate News Blog - GSK's Shingles Vaccine with Agenus' QS-21 Stimulon(R) Adjuvant Gets FDA Approval in US ACCESSWIRE
04:01AM  The common bonus structures that can lead to corporate corruption scandals Quartz
Oct-23-17 06:16PM  Is Celgene (CELG) Poised for a Beat This Earnings Season? Zacks
10:03AM  Is Gilead (GILD) Poised for a Beat This Earnings Season? Zacks
04:22AM  GSK wins U.S. shingles vaccine approval, UK nod for gene therapy Reuters
Oct-22-17 07:24PM  Britain backs GSK's gene therapy for 'bubble boy' syndrome Reuters
Oct-20-17 07:18PM  GlaxoSmithKline adult shingles vaccine wins U.S. approval Reuters
07:16PM  Shingrix approved in the US for prevention of shingles in adults aged 50 and over PR Newswire
06:54PM  GlaxoSmithKline adult shingles vaccine wins U.S. approval Reuters
04:36PM  Novo Nordisk Stock: Performance in 3Q17 Market Realist
10:55AM  Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again? Zacks
10:00AM  3 High-Yield Pharmaceutical Stocks Motley Fool
Oct-19-17 05:00PM  China Biotech Promise Struggles to Keep Foreign Innovators Bloomberg
09:00AM  Novartis Reports Positive Results on Thrombocytopenia Drug Zacks
Oct-18-17 04:21PM  What to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
07:42AM  What GlaxoSmithKlines 3Q17 Performance Tells Us Market Realist
Oct-16-17 06:07PM  Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada Zacks
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories under the Otrivin, Panadol, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. GlaxoSmithKline plc has a strategic drug discovery collaboration with Exscientia Limited to discover novel and selective small molecules for up to 10 disease-related targets across various therapeutic areas; and a collaboration agreement with Oklahoma Medical Research Foundation for the discovery, development, and commercialization of therapies to prevent organ damage and death caused by acute pancreatitis, lung injury, and trauma conditions. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerNov 06Buy14.00428,5715,999,9941,854,006Nov 07 07:42 PM